METTLER TOLEDO INTERNATIONAL INC/ MTD

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $1,418.60
Market Cap $28.92B
P/E Ratio 33.74
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑4.0% YoY
$4.03B
3-Yr CAGR: 0.9%
Net Income ↑0.7% YoY
$869.19M
Net Margin: 21.6%
Free Cash Flow ↓-1.8% YoY
$848.65M
FCF Yield: 2.93%
EPS (Diluted) ↑3.9% YoY
$42.05
Basic: $42.17
Return on Equity Efficiency
N/A
ROA: 23.4%
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (MTD)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $2,508.3M $1,435.6M $0.0M $14.22 $443.1M $319.1M
FY 2017 $2,725.1M +8.6% $1,573.3M $0.0M +0.1% $14.24 +0.1% $516.3M $388.9M +21.9%
FY 2018 $2,935.6M +7.7% $1,684.4M $512.6M +3,599,796,248.3% $19.88 +39.6% $565.0M $422.3M +8.6%
FY 2019 $3,008.7M +2.5% $1,741.2M $561.1M +9.5% $22.47 +13.0% $603.5M $506.1M +19.9%
FY 2020 $3,085.2M +2.5% $1,801.0M $602.7M +7.4% $24.91 +10.9% $724.7M $632.2M +24.9%
FY 2021 $3,717.9M +20.5% $2,171.6M $769.0M +27.6% $32.78 +31.6% $908.8M $801.2M +26.7%
FY 2022 $3,919.7M +5.4% $2,308.0M $872.5M +13.5% $38.41 +17.2% $859.1M $737.8M -7.9%
FY 2023 $3,788.3M -3.4% $2,241.3M $788.8M -9.6% $35.90 -6.5% $965.9M $860.6M +16.6%
FY 2024 $3,872.4M +2.2% $2,325.6M $863.1M +9.4% $40.48 +12.8% $968.3M $864.4M +0.5%
FY 2025 $4,026.4M +4.0% $2,390.6M $869.2M +0.7% $42.05 +3.9% $955.8M $848.6M -1.8%
$

Valuation

Market Price $1,418.60
Market Cap $28.92B
Enterprise Value $31.00B
P/E Ratio 33.74
P/B Ratio N/A
FCF Yield 2.93%
Dividend Yield N/A
Shares Outstanding 20,207,600
%

Profitability & Margins

Gross Margin 59.37%
Operating Margin 0.42%
Net Margin 21.59%
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) 23.41%
Asset Turnover 1.08x
Revenue 3-Yr CAGR 0.90%
🛡️

Financial Health & Liquidity

Current Ratio 0.55
Cash Ratio 0.28
Debt / Equity -91.055
Debt / Assets 0.580
Cash & Equivalents $66.89M
Total Debt $2.15B
Book Value / Share $-1.17
💧

Cash Flow Efficiency

Operating Cash Flow $955.77M
Capital Expenditures (CapEx) $107.12M
Free Cash Flow $848.65M
OCF / Revenue 23.74%
FCF / Revenue 21.08%
FCF 3-Yr CAGR 4.78%
🏷️

Per Share Metrics

EPS (Diluted) $42.05
EPS (Basic) $42.17
Dividends / Share N/A
Book Value / Share $-1.17
EPS YoY Growth 3.88%
🏛️

Balance Sheet (FY 2025)

Total Assets $3.71B
Total Liabilities $3.74B
Stockholders' Equity -$23.64M
Current Assets $130.31M
Current Liabilities $237.48M